May 9, 2017 / 4:24 PM / 3 months ago

BRIEF-U.S. FDA grants accelerated approval to Avelumab for Urothelial Carcinoma

May 9 (Reuters) - U.S. FDA:

* U.S. Food and Drug Administration grants accelerated approval to avelumab for urothelial carcinoma Source text (bit.ly/2pgHp8q) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below